Loading...
Email
Linkedin
Facebook
X
Copy Link
TranscriptOur latest C-Suite Outlook 2024 survey results show that an economic downturn is still a top concern for both CEOs and CMOs. Yet, CMOs are optimistic, saying they can still drive growth in this environment. What strategies and investments are CMOs planning to use to achieve this—and do they differ from the CEO view?
In this episode of C-Suite Perspectives, Ivan Pollard, Center Leader, Marketing & Communications, joins President and CEO Steve Odland, both of The Conference Board, to discuss the survey results and the implications for the marketing & communications landscape in 2024.
Tune in to find out:
For more Trusted Insights for What’s Ahead®:
C-Suite Perspectives is a series hosted by our President & CEO, Steve Odland. This weekly conversation takes an objective, data-driven look at a range of business topics aimed at executives. Listeners will come away with what The Conference Board does best: Trusted Insights for What’s Ahead®.
C-Suite Perspectives provides unique insights for C-Suite executives on timely topics that matter most to businesses as selected by The Conference Board. If you would like to suggest a guest for the podcast series, please email csuite.perspectives@conference-board.org. Note: As a non-profit organization under 501(c)(3) of the IRS Code, The Conference Board cannot promote or offer marketing opportunities to for-profit entities.
C-Suite Perspectives / 04 Aug 2025
More C-Suite leaders view their boards as effective in 2025, but numerous challenges remain, including keeping up with AI.
C-Suite Perspectives / 29 Jul 2025
We break down the latest data from The Conference Board Consumer Confidence Index®, released today.
C-Suite Perspectives / 28 Jul 2025
Learn how Clorox invested in technological innovation so it could continue delivering superior consumer experiences.
C-Suite Perspectives / 21 Jul 2025
2025 is half over. What issues should human capital leaders focus on during the rest of the year?
C-Suite Perspectives / 14 Jul 2025
Learn why culture and constant innovation are essential to developing life-changing biopharma treatments.
C-Suite Perspectives / 07 Jul 2025
We've just passed the midway point of 2025 -- what are the top 10 priorities for chief marketing officers (CMOs) for the rest of the year?
